Retroperitoneal LiposarcomaSymptoms, Doctors, Treatments, Advances & More
Learn About Retroperitoneal Liposarcoma
UT MD Anderson Cancer Center
Christina Roland is a Surgical Oncologist practicing medicine in Cary, North Carolina. Dr. Roland is rated as an Elite provider by MediFind in the treatment of Retroperitoneal Liposarcoma. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Undifferentiated Pleomorphic Sarcoma, Adult Soft Tissue Sarcoma, Liposarcoma, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.
Dana-Farber Cancer Institute, Sarcoma And Bone Cancer Treatment Center
Chandrajit Raut is a Surgical Oncologist practicing medicine in Boston, Massachusetts. Dr. Raut is rated as an Elite provider by MediFind in the treatment of Retroperitoneal Liposarcoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Angiosarcoma, Nephrectomy, and Pancreaticoduodenectomy. Dr. Raut is board certified in Surgery, General. Dr. Raut is currently accepting new patients.
Winship Cancer Institute At Emory Midtown
Kenneth Cardona is a Surgical Oncologist practicing medicine in Atlanta, Georgia. Dr. Cardona is rated as an Elite provider by MediFind in the treatment of Retroperitoneal Liposarcoma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Retroperitoneal Liposarcoma, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Cardona is board certified in American Board Of Surgery, 2010. Dr. Cardona is currently accepting new patients.
Summary: The aim of the study is to collect prospective data on the treatment outcomes in patients with first localized, resectable recurrent retroperitoneal well-differentiated and/or dedifferentiated liposarcoma undergoing curative intent treatment. Patients enrolled in this study will form a validation cohort of the TARPSWG recurrent RPS nomogram. The treatment decision (surgery alone, or preoperative R...
Summary: The protocol intends to explore the biology which may underlie recurrences of retroperitoneal liposarcoma. Surgery remains the only curative intent intervention for this disease. Often, tumors recur in locations within the retroperitoneum remote from the original primary tumor. This study hypothesizes that normal appearing retroperitoneal fat actually harbors underlying genetic changes which predi...
Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center